A recent health and anti-aging study suggests that you can reduce the risk of cancer with Aspirin daily. This study showed a reduction in risk of certain cancers, as well as avoiding tumors from spreading. On the downside, it could lead to a risk of gastrointestinal bleeding, however, as well as other side effects, when taken regularly. On the other hand, it can be a great weapon in combating cancer. The recent study was conducted by University of Oxford researchers, who studied thousands of men and women in controlled trials.  The results of one paper after…

  • Three Years:  25% reduction in the risk of developing cancer (compared to those who did not take aspirin).
  • Five Years:  37% reduction in the risk of dying of cancer (compared to those who did not take aspirin).

There are obvious benefits to taking aspirin as a precaution against developing or dying from cancer. So, consider talking to your health care professional to weigh the pros and cons.

In separate paper with controlled studies, taking aspirin daily actually:

  • reduced the risk of metastatic cancer by 37%
  • reduced the risk of adenocarcinomas by 46% (such as lung, colon and prostate cancers)
  • reduced the risk of progressing to metastatic colorectal cancer
  • after taking aspirin  for 6 1/2 years

In a third paper, researchers compared the findings of the observational studies and those randomized trials. The doctor who led the studies, Dr. Rothwell,  believes there is an urgency to conduct further clinical trials where aspirin is incorporated in the treatment.  One of the best results comes with the 75% reduction in esophageal cancer and the 40-50% reduction in colorectal cancer. According to Dr. Rothwell, “… anyone with a family history would be sensible to take aspirin.” The problem with that lies in the risks that come with aspirin therapy, such as the above-mentioned gastrointestinal bleeding, and also hemorrhagic strokes.  However, the findings also state that the risk of bleeding diminishes with time. Moreover, hemorrhagic strokes were higher in a comparison group that did not take aspirin.

Even the American Cancer Society is paying close attention to these findings, although they remain cautious. There is excitement about it being used as a chemopreventative agent, however. Ironically, the studies were conducted to understand how aspirin prevents heart disease and not about cancer prevention. Previous studies conducted in the United States using low-dose aspirin for cancer prevention did not find similar results, as subjects were advised to take aspirin only every other day, and not every day as in the Oxford studies.  Because of the risks involved with long-term use of aspirin, most doctors are reluctant to recommend it, unless of course, the benefits outweigh the risks.

Unfortunately, it is unlikely for other long-term trials to be done because of the overwhelming costs involved, and the fact that aspirin is extremely inexpensive. Before deciding on your options, talk to your doctor.